American Journal of Ophthalmology
Volume 143, Issue 4 , Pages 561-565.e1 , April 2007

Costs of Interventions for Visual Impairment

  • Hugh R. Taylor

      Affiliations

    • Centre for Eye Research Australia, University of Melbourne, World Health Organization (WHO) Collaborating Centre for the Prevention of Blindness, East Melbourne Victoria, Australia
    • Corresponding Author InformationInquiries to Hugh R. Taylor, Centre for Eye Research Australia, University of Melbourne, 32 Gisborne Street, East Melbourne, Victoria, Australia 3002
    • ,
  • M. Lynne Pezzullo

      Affiliations

    • Access Economics Pty Limited, Barton Australia Capital Territory, Australia
    • ,
  • Sarah J. Nesbitt

      Affiliations

    • Access Economics Pty Limited, Barton Australia Capital Territory, Australia
    • ,
  • Jill E. Keeffe

      Affiliations

    • Centre for Eye Research Australia, University of Melbourne, World Health Organization (WHO) Collaborating Centre for the Prevention of Blindness, East Melbourne Victoria, Australia
    • Vision Cooperative Research Centre, University of New South Wales, Sydney New South Wales, Australia.

,Accepted 27 October 2006.

References 

  1. Resnikoff , Pascolini D, Etya’ale D, et al. Global data on visual impairment in the year 2002. Bull World Health Organ. 2004;844–851
  2. Pascolini D, Mariotti SP, Pokharel GP, et al. 2002 Global update of available data on visual impairment: a compilation of population-based prevalence studies. Ophthalmic Epidemiol. 2004;11:67–115
  3. Pararajasegaram R. VISION 2020—The Right to Sight: from strategies to action. Am J Ophthalmol. 1999;128:359–360
  4. VISION 2020: The Right to Sight. Available at: http://www.v2020.org.
  5. Taylor HR, Livingston PM, Stanislavsky YL, et al. Visual impairment in Australia: distance and near visual acuity and visual field findings of the Melbourne Visual Impairment Project. Am J Ophthalmol. 1997;123:328–337
  6. Congdon N, O’Colmain B, Klaver CC, et al. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 2004;122:477–485
  7. Taylor HR, Pezzullo ML, Keeffe JE. The economic impact and cost of visual impairment in Australia. Br J Ophthalmol. 2006;90:272–275
  8. Frick KD, Kymes SM. The calculation and use of economic burden data. Br J Ophthalmol. 2006;90:255–257
  9. Taylor HR, Keeffe JE, Vu HTV, et al. Vision loss in Australia. Med J Aust. 2005;182:565–568
  10. Centre for Eye Research Australia. Clear insight: the economic impact and cost of vision loss in Australia. Melbourne: Centre for Eye Research Australia; 2004;
  11. Australian Institute of Health and Welfare. Health system expenditure on disease and injury in Australia, 2000–2001 (Health and Welfare Expenditure Series 19). Canberra: Australian Institute of Health and Welfare; 2004;
  12. Mathers C, Vos T, Stevenson C. The burden of disease and injury in Australia (PHE-17). Canberra: Australian Institute of Health and Welfare; 1999;
  13. Centre for Eye Research Australia. Investing in sight: strategic interventions to prevent vision loss in Australia. Melbourne: Centre for Eye Research Australia; 2005;
  14. Australian Bureau of Statistics. 2001 Census: basic community profiles and snapshots. Australian Bureau of Statistics 2002; http://www.abs.gov.au. Date accessed: August 12, 2006.
  15. Taylor HR. Eye care for the future: the Weisenfeld lecture. Invest Ophthalmol Vis Sci. 2003;44:1413–1418
  16. Brown MM, Brown GC. How to interpret a healthcare economic analysis. Curr Opin Ophthalmol. 2005;16:191–194
  17. World Health Organization. Global initiative for the elimination of avoidable blindness (PBL/97.61). Geneva: World Health Organization; 1997;
  18. Busbee BG, Brown MM, Brown GC, et al. Cost-utility analysis of cataract surgery in the second eye. Ophthalmology. 2003;110:2310–2317
  19. Smith W, Assink J, Klein R, et al. Risk factors for age-related macular degeneration: pooled findings from three continents. Ophthalmology. 2001;108:697–704
  20. McCarty CA, Mukesh BN, Fu CL, et al. The epidemiology of cataract in Australia. Am J Ophthalmol. 1999;128:446–465
  21. Frick KD, Foster A. The magnitude and cost of global blindness: an increasing that can be alleviated. Am J Ophthalmol. 2003;135:471–476
  22. Frick KD, Foster A, Bah M, et al. Analysis of costs and benefits of the Gambian eye care program. Arch Ophthalmol. 2005;123:239–243
  23. World Health Organization. Resolution of the World Health Assembly on the elimination of avoidable blindness. WHO, Geneva, WHA. 2006;56:26
  24. World Health Organization. Resolution of the World Health Assembly on prevention of avoidable blindness and visual impairment. WHO, Geneva, WHA. 2006;59:25

PII: S0002-9394(06)01256-6

doi: 10.1016/j.ajo.2006.10.055

American Journal of Ophthalmology
Volume 143, Issue 4 , Pages 561-565.e1 , April 2007

Article Tools